158 related articles for article (PubMed ID: 38451956)
1. Cervical cancer prevention: Feasibility of self-sampling and HPV testing in rural and urban areas of Bolivia: An observational study.
Carozzi FM; Royder Yanez R; Paganini I; Sani C; Cannistrà S; Matucci M; von Borries S; Traina S
PLoS One; 2024; 19(3):e0292605. PubMed ID: 38451956
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the self-sampling for cervical cancer screening in Bolivia.
Allende G; Surriabre P; Cáceres L; Bellot D; Ovando N; Torrico A; Calle P; Ascarrunz C; Alexander S; Bossens M; Fontaine V; Rodríguez P
BMC Public Health; 2019 Jan; 19(1):80. PubMed ID: 30654774
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of viral sexually transmitted infections and HPV high-risk genotypes in women in rural communities in the Department of La Paz, Bolivia.
Patzi-Churqui M; Terrazas-Aranda K; Liljeqvist JÅ; Lindh M; Eriksson K
BMC Infect Dis; 2020 Mar; 20(1):204. PubMed ID: 32143643
[TBL] [Abstract][Full Text] [Related]
4. Detection and genotyping of HPV-DNA through different types of diagnostic platforms in liquid-based cervical-cytology samples.
Cassani B; Soldano G; Finocchiaro D; Conti S; Bulfamante A; Lemorini G; Bulfamante G
Pathologica; 2018 Dec; 110(4):294-301. PubMed ID: 30799441
[TBL] [Abstract][Full Text] [Related]
5. Implementation of HPV-based Cervical Cancer Screening Combined with Self-sampling Using a Midwifery Network Across Rural Greece: The GRECOSELF Study.
Agorastos T; Chatzistamatiou K; Tsertanidou A; Mouchtaropoulou E; Pasentsis K; Kitsou A; Moysiadis T; Moschaki V; Skenderi A; Katsiki E; Aggelidou S; Venizelos I; Ntoula M; Daponte A; Vanakara P; Garas A; Stefos T; Vrekoussis T; Lymberis V; Kontomanolis EN; Makrigiannakis A; Manidakis G; Deligeoroglou E; Panoskaltsis T; Decavalas GO; Michail G; Kalogiannidis I; Koukoulis G; Zempili P; Halatsi D; Truva T; Piha V; Agelena G; Chronopoulou A; Vaitsi V; Chatzaki E; Paschopoulos M; Adonakis G; Kaufmann AM; Hadzidimitriou A; Stamatopoulos K
Cancer Prev Res (Phila); 2019 Oct; 12(10):701-710. PubMed ID: 31427275
[TBL] [Abstract][Full Text] [Related]
6. Self-sampling for human papillomavirus DNA detection: a preliminary study of compliance and feasibility in BOLIVIA.
Surriabre P; Allende G; Prado M; Cáceres L; Bellot D; Torrico A; Ustariz K; Rojas S; Barriga J; Calle P; Villarroel L; Yañez RM; Baay M; Rodriguez P; Fontaine V
BMC Womens Health; 2017 Dec; 17(1):135. PubMed ID: 29273032
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the effectiveness of high-risk human papilloma self-sampling test for cervical cancer screening in Bolivia.
Allende G; Surriabre P; Ovando N; Calle P; Torrico A; Villarroel J; Bossens M; Fontaine V; Rodriguez P
BMC Infect Dis; 2020 Apr; 20(1):259. PubMed ID: 32245369
[TBL] [Abstract][Full Text] [Related]
8. [Real-world research on cervical cancer screening program and effect evaluation for Chinese population].
Zhao YQ; Dai Y; Dang L; Kong LH; Zhang Y; Feng RM; Qiao YL; Lang JH
Zhonghua Zhong Liu Za Zhi; 2018 Oct; 40(10):764-771. PubMed ID: 30392341
[No Abstract] [Full Text] [Related]
9. Integrating human papillomavirus testing as a point-of care service using GeneXpert platforms: Findings and lessons from a Kenyan pilot study (2019-2020).
Mwenda V; Bor JP; Nyangasi M; Njeru J; Olwande S; Njiri P; Arbyn M; Weyers S; Tummers P; Temmerman M
PLoS One; 2023; 18(5):e0286202. PubMed ID: 37228154
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of positive screening test results and agreement between cytology and human papillomavirus testing in primary cervical cancer screening in North-Western Romania.
Şuteu O; Blaga ML; Nygård M; Leinonen MK; Nicula F; Păiş R; Coza D; Cadariu PA; Melnic A; Andreassen T; Hashim D; Weiderpass E
Eur J Cancer Prev; 2020 Mar; 29(2):141-148. PubMed ID: 31033568
[TBL] [Abstract][Full Text] [Related]
11. Use of Fast Transfer Analysis Cartridges for Cervical Sampling and Real Time PCR Based High Risk HPV Testing in Cervical Cancer Prevention - a Feasibility Study from South India.
Vijayalakshmi R; Viveka TS; Malliga JS; Murugan K; Kanchana A; Arvind K
Asian Pac J Cancer Prev; 2015; 16(14):5993-9. PubMed ID: 26320486
[TBL] [Abstract][Full Text] [Related]
12. Self-collected versus clinician-collected cervical samples for the detection of HPV infections by 14-type DNA and 7-type mRNA tests.
Aranda Flores CE; Gomez Gutierrez G; Ortiz Leon JM; Cruz Rodriguez D; Sørbye SW
BMC Infect Dis; 2021 May; 21(1):504. PubMed ID: 34058992
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and sociodemographic predictors of high-risk vaginal human papillomavirus infection: findings from a public cervical cancer screening registry.
Jailani AS; Balqis-Ali NZ; Tang KF; Fun WH; Samad SA; Jahaya R; Subakir NN; Ismail R; Said ZM; Sararaks S
BMC Public Health; 2023 Nov; 23(1):2243. PubMed ID: 37964260
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and genotype-specific distribution of human papillomavirus in Burundi according to HIV status and urban or rural residence and its implications for control.
Ndizeye Z; Vanden Broeck D; Lebelo RL; Bogers J; Benoy I; Van Geertruyden JP
PLoS One; 2019; 14(6):e0209303. PubMed ID: 31237894
[TBL] [Abstract][Full Text] [Related]
15. Self-collected cervicovaginal sampling for site-of-care primary HPV-based cervical cancer screening: a pilot study in a rural underserved Greek population.
Chatzistamatiou K; Chatzaki Ε; Constantinidis Τ; Nena E; Tsertanidou A; Agorastos T
J Obstet Gynaecol; 2017 Nov; 37(8):1059-1064. PubMed ID: 28631511
[TBL] [Abstract][Full Text] [Related]
16. Assessing the impact of mailing self-sampling kits for human papillomavirus testing to unscreened non-responder women in Manitoba.
Jalili F; O'Conaill C; Templeton K; Lotocki R; Fischer G; Manning L; Cormier K; Decker K
Curr Oncol; 2019 Jun; 26(3):167-172. PubMed ID: 31285661
[TBL] [Abstract][Full Text] [Related]
17. High-risk human papillomavirus detection in self-collected vaginal samples compared with healthcare worker collected cervical samples among women attending gynecology clinics at a tertiary hospital in Pretoria, South Africa.
Tiiti TA; Mashishi TL; Nkwinika VV; Benoy I; Selabe SG; Bogers J; Lebelo RL
Virol J; 2021 Sep; 18(1):192. PubMed ID: 34556128
[TBL] [Abstract][Full Text] [Related]
18. A pilot study of HPV DNA and cytology testing in 50,159 women in the routine Mexican Social Security Program.
Lazcano-Ponce E; Lörincz AT; Salmerón J; Fernández I; Cruz A; Hernández P; Mejia I; Hernández-Avila M
Cancer Causes Control; 2010 Oct; 21(10):1693-700. PubMed ID: 20617376
[TBL] [Abstract][Full Text] [Related]
19. Home-based HPV self-sampling assisted by a cloud-based electronic data system: Lessons learnt from a pilot community cervical cancer screening campaign in rural Ethiopia.
Jede F; Brandt T; Gedefaw M; Wubneh SB; Abebe T; Teka B; Alemu K; Tilahun B; Azemeraw T; Gebeyehu A; Schmidt D; Pesic A; Kaufmann AM; Abebe B; Ayichew Z; Byczkowski M; Vaucher T; Sartor H; Andargie G; Bärnighausen T; von Knebel Doeberitz M; Bussmann H
Papillomavirus Res; 2020 Jun; 9():100198. PubMed ID: 32416283
[TBL] [Abstract][Full Text] [Related]
20. PCR-reverse dot blot human papillomavirus genotyping as a primary screening test for cervical cancer in a hospital-based cohort.
Kang Y; Sun P; Mao X; Dong B; Ruan G; Chen L
J Gynecol Oncol; 2019 May; 30(3):e29. PubMed ID: 30887754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
